Prosper Junior Bakiny
TMFPBakiny
Prosper Junior Bakiny is a contributing Motley Fool healthcare analyst covering biotechnology, pharmaceuticals, and healthcare stocks. Before The Motley Fool, Prosper wrote about investing topics ranging from stock market news to private equity for various companies. He holds a master’s degree in corporate finance from the University of Maryland Global Campus.
Recent Articles by Prosper Junior Bakiny

Jan 26, 2025
by Prosper Junior Bakiny
Where Will Tilray Brands Be in 5 Years?

Jan 23, 2025
by Prosper Junior Bakiny
Can This Beaten-Down Stock Bounce Back in 2025?

Jan 17, 2025
by Prosper Junior Bakiny
Can Teladoc Stock Bounce Back in 2025?

Jan 13, 2025
by Prosper Junior Bakiny
2 Beaten-Down Dividend Stocks to Buy in 2025

Jan 4, 2025
by Prosper Junior Bakiny
Better Buy: Novo Nordisk vs. AstraZeneca

Dec 27, 2024
by Prosper Junior Bakiny
2 Brilliant Stocks to Buy and Hold for 10 Years
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.